EP1578945A3 - Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren - Google Patents

Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren

Info

Publication number
EP1578945A3
EP1578945A3 EP03789986.1A EP03789986A EP1578945A3 EP 1578945 A3 EP1578945 A3 EP 1578945A3 EP 03789986 A EP03789986 A EP 03789986A EP 1578945 A3 EP1578945 A3 EP 1578945A3
Authority
EP
European Patent Office
Prior art keywords
cct6s
modifiers
pathway
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03789986.1A
Other languages
English (en)
French (fr)
Other versions
EP1578945A2 (de
EP1578945A4 (de
Inventor
Albert K. Tai
Chunyan Song
Michael Martin Ollmann
Lucile A. Gillett
Kim Lickteig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Priority claimed from PCT/US2003/037548 external-priority patent/WO2004048541A2/en
Publication of EP1578945A3 publication Critical patent/EP1578945A3/de
Publication of EP1578945A2 publication Critical patent/EP1578945A2/de
Publication of EP1578945A4 publication Critical patent/EP1578945A4/de
Withdrawn legal-status Critical Current

Links

EP03789986A 2002-11-25 2003-11-24 Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren Withdrawn EP1578945A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42887202P 2002-11-25 2002-11-25
US428872P 2002-11-25
PCT/US2003/037548 WO2004048541A2 (en) 2002-11-25 2003-11-24 Cct6s as modifiers of the rb pathway and methods of use

Publications (3)

Publication Number Publication Date
EP1578945A3 true EP1578945A3 (de) 2005-08-18
EP1578945A2 EP1578945A2 (de) 2005-09-28
EP1578945A4 EP1578945A4 (de) 2006-09-27

Family

ID=32393472

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03789986A Withdrawn EP1578945A4 (de) 2002-11-25 2003-11-24 Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren

Country Status (5)

Country Link
EP (1) EP1578945A4 (de)
JP (1) JP4646631B2 (de)
AU (2) AU2003294499A1 (de)
CA (1) CA2506686A1 (de)
WO (2) WO2004048541A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008133904A1 (en) 2007-04-23 2008-11-06 Stowers Institute For Medical Research Methods and compositions for stem cell self-renewal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071715A (en) * 1993-08-12 2000-06-06 Board Of Regents, The University Of Texas System Nucleic acids encoding novel proteins which bind to retinoblastoma protein
GB9608937D0 (en) * 1996-04-29 1996-07-03 Cancer Res Campaign Tech Screening methods for therapeutics and peptides used in the screen
EP1054969A2 (de) * 1998-02-12 2000-11-29 Curagen Corporation Retinoblastomprotein komplexe und proteine die mit dem retinoblastomprotein wechsel wirken

Similar Documents

Publication Publication Date Title
AU2003224638A1 (en) PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003248879A1 (en) RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003272400A1 (en) Syts as modifiers of the p21 pathway and methods of use
AU2003251799A1 (en) Mchks as modifiers of the chk1 pathway and methods of use
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003295881A1 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003265263A1 (en) ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
EP1578945A3 (de) Cct6s als modifikatoren des rb-wegssowie verwendungsverfahren
AU2003294499A1 (en) Rhebs as modifiers of the rb pathway and methods of use
AU2003303094A1 (en) MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003251826A1 (en) Mp21s as modifiers of the p21 pathway and methods of use
AU2003258095A1 (en) MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003299990A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003217851A1 (en) MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
AU2003213693A1 (en) MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
AU2003213665A1 (en) Lgals as modifiers of the chk pathway and methods of use
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003278811A1 (en) LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003248876A1 (en) MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003295928A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003213662A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003223208A1 (en) MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003215004A1 (en) Msrebps as modifiers of the srebp pathway and methods of use
EP1587910A4 (de) Facls als modifikatoren des rb-wegs undverwendungsverfahren
EP1633852A4 (de) Sppls als modifikatoren des p53-wegs und verwendungsverfahren